NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Aprogen KIC Inc (KO: 007460)

 
007460 Technical Analysis
5
As on 13th Feb 2026 007460 STOCK Price closed @ 502.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 713.69 & Strong Sell for SHORT-TERM with Stoploss of 803.45 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

007460STOCK Price

Open 498.00 Change Price %
High 526.00 1 Day -13.00 -2.52
Low 444.00 1 Week -178.00 -26.18
Close 502.00 1 Month -208.00 -29.30
Volume 25578662 1 Year -421.00 -45.61
52 Week High 937.00 | 52 Week Low 502.00
 
KO Korea Most Active Stocks
001510 1215.00 29.95%
001510 1215.00 29.95%
093230 33.00 -49.23%
093230 33.00 -49.23%
018880 4460.00 1.59%
018880 4460.00 1.59%
003530 7360.00 13.23%
003530 7360.00 13.23%
004060 456.00 4.35%
004060 456.00 4.35%
 
KO Korea Top Gainers Stocks
119650 1581.67 244.59%
119650 1581.67 244.59%
071670 10060.00 70.51%
071670 10060.00 70.51%
001515 3470.00 29.96%
001515 3470.00 29.96%
001510 1215.00 29.95%
001510 1215.00 29.95%
168490 159.00 29.27%
168490 159.00 29.27%
 
KO Korea Top Losers Stocks
001140 14.00 -83.53%
001140 14.00 -83.53%
002210 973.00 -65.00%
002210 973.00 -65.00%
002210 973.00 -65.00%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
093230 33.00 -49.23%
 
 
007460
Daily Charts
007460
Intraday Charts
Whats New @
Bazaartrend
007460
Free Analysis
 
007460 Important Levels Intraday
RESISTANCE660.01
RESISTANCE609.34
RESISTANCE578.01
RESISTANCE546.69
SUPPORT457.31
SUPPORT425.99
SUPPORT394.66
SUPPORT343.99
 
007460 Forecast February 2026
4th UP Forecast825.74
3rd UP Forecast721.91
2nd UP Forecast657.74
1st UP Forecast593.56
1st DOWN Forecast410.44
2nd DOWN Forecast346.26
3rd DOWN Forecast282.09
4th DOWN Forecast178.26
 
007460 Weekly Forecast
4th UP Forecast771.78
3rd UP Forecast685.26
2nd UP Forecast631.78
1st UP Forecast578.30
1st DOWN Forecast425.70
2nd DOWN Forecast372.22
3rd DOWN Forecast318.74
4th DOWN Forecast232.22
 
007460 Forecast2026
4th UP Forecast1742.99
3rd UP Forecast1345
2nd UP Forecast1098.99
1st UP Forecast852.98
1st DOWN Forecast151.02
2nd DOWN Forecast-94.99
3rd DOWN Forecast-341
4th DOWN Forecast-738.99
 
 
007460 Other Details
Segment EQ
Market Capital 362458447872.00
Sector Industrials
Industry Specialty Industrial Machinery
Offical website >
 
007460 Address
007460
 
007460 Latest News
 
Your Comments and Response on Aprogen KIC Inc
 
007460 Business Profile
Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foamglas, a cellular glass insulation product; and fireproof insulation works in the POSCO furnaces and boilers. The company was formerly known as Aprogen KIC Inc. and changed its name to Aprogen Medicines Inc. April 2021. Aprogen Medicines Inc. was founded in 1971 and is based in Seongnam-si, South Korea. Address: Hallasigma valley (Sangdaewon-dong), Seongnam-si, South Korea
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service